CAPRICOR THERAPEUTICS, INC. (CAPR) › Operating Cash FlowCAPRICOR THERAPEUTICS, INC. (CAPR) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$4.32M2011: -$4.65M2016: -$14.45M2017: -$14.23M2018: -$13.86M2019: -$6.82M2020: -$10.05M2021: -$16.81M2022: $4.92M2023: -$25.60M2024: -$40.00M2025: -$69.81M-$69.81M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$69.81M-74.5%2024-$40.00M-56.3%2023-$25.60M-620.6%2022$4.92M+129.2%2021-$16.81M-67.2%2020-$10.05M-47.4%2019-$6.82M+50.8%2018-$13.86M+2.6%2017-$14.23M+1.5%2016-$14.45M—2011-$4.65M-7.7%2010-$4.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share